Goldman Sachs Group Inc Edgewise Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 482,225 shares of EWTX stock, worth $14.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
482,225
Previous 1,622,741 70.28%
Holding current value
$14.8 Million
Previous $29.2 Million 55.96%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.88 - $29.5 $18.1 Million - $33.6 Million
-1,140,516 Reduced 70.28%
482,225 $12.9 Million
Q2 2024

Aug 13, 2024
SELL
$15.08 - $21.23 $1.89 Million - $2.66 Million
-125,103 Reduced 7.16%
1,622,741 $29.2 Million
Q1 2024

May 15, 2024
BUY
$9.25 - $19.97 $8.01 Million - $17.3 Million
865,948 Added 98.19%
1,747,844 $31.9 Million
Q4 2023

Feb 13, 2024
SELL
$5.51 - $12.1 $363,097 - $797,365
-65,898 Reduced 6.95%
881,896 $9.65 Million
Q3 2023

May 14, 2024
BUY
$5.73 - $7.69 $377,595 - $506,755
65,898 Added 7.47%
947,794 $5.43 Million
Q3 2023

Nov 14, 2023
SELL
$5.73 - $7.69 $4.62 Million - $6.2 Million
-806,055 Reduced 45.96%
947,794 $5.43 Million
Q2 2023

May 14, 2024
BUY
$5.71 - $10.29 $5.71 Million - $10.3 Million
999,710 Added 132.56%
1,753,849 $13.6 Million
Q2 2023

Aug 14, 2023
BUY
$5.71 - $10.29 $5.71 Million - $10.3 Million
999,710 Added 132.56%
1,753,849 $13.6 Million
Q1 2023

May 14, 2024
SELL
$6.66 - $11.33 $2.07 Million - $3.52 Million
-310,982 Reduced 29.2%
754,139 $5.03 Million
Q1 2023

May 11, 2023
SELL
$6.66 - $11.33 $2.07 Million - $3.52 Million
-310,982 Reduced 29.2%
754,139 $5.03 Million
Q4 2022

May 14, 2024
BUY
$7.58 - $11.08 $7.6 Million - $11.1 Million
1,002,520 Added 1601.44%
1,065,121 $9.52 Million
Q4 2022

Feb 13, 2023
BUY
$7.58 - $11.08 $7.6 Million - $11.1 Million
1,002,520 Added 1601.44%
1,065,121 $9.52 Million
Q3 2022

May 14, 2024
SELL
$8.08 - $13.58 $672,369 - $1.13 Million
-83,214 Reduced 57.07%
62,601 $616,000
Q3 2022

Nov 10, 2022
SELL
$8.08 - $13.58 $672,369 - $1.13 Million
-83,214 Reduced 57.07%
62,601 $615,000
Q2 2022

May 14, 2024
SELL
$5.67 - $9.87 $4.17 Million - $7.27 Million
-736,081 Reduced 83.47%
145,815 $1.16 Million
Q2 2022

Aug 15, 2022
BUY
$5.67 - $9.87 $77,389 - $134,715
13,649 Added 10.33%
145,815 $1.16 Million
Q1 2022

May 16, 2022
BUY
$9.1 - $18.97 $834,051 - $1.74 Million
91,654 Added 226.24%
132,166 $1.28 Million
Q4 2021

Feb 14, 2022
BUY
$14.41 - $22.41 $583,777 - $907,873
40,512 New
40,512 $619,000

Others Institutions Holding EWTX

# of Institutions
191
Shares Held
100M
Call Options Held
2.17M
Put Options Held
410K
View Full List

About Edgewise Therapeutics, Inc.

EWTX Quotes by TradingView
  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.94B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email